-
Mouse data
Counts of adults worms and miracidea of 3 different lines (susceptible, resistant and mixed resistant-susceptible) inside the mouse host exposed to three different treatments:... -
Using focused pharmacovigilance for ensuring patient safety against antileish...
Abstract Background Adverse effects of antileishmanial drugs can affect patients’ quality of life and adherence to therapy for visceral leishmaniasis (VL) and post-kala-azar... -
Drug regimen for MDAs and treatment of <i>Strongyloides</i>.
Drug regimen for MDAs and treatment of Strongyloides. -
r37980778c78--8b3d85681e34010f2ff6b04d1cf898ec
Mean intensity of infection corresponds with the mean fecal egg counts (FEC; expressed as eggs per gram of stool (EPG)) for a single (1x KK) and duplicate (2x KK) Kato-Katz,... -
r37980778c78--f4e116f4d24cd67cf4a7ecabbe5429f8
In vivo toxicity of CBD in L. donovani infected mice. -
Efficacy of single versus four repeated doses of praziquantel against <i>Schi...
BackgroundPreventive chemotherapy with praziquantel (PZQ) is the cornerstone of schistosomiasis control. However, a single dose of PZQ (40 mg/kg) does not cure all infections.... -
r37980778c78--51e5b2c312287538bf31cb62db4f3314
Scenarios on the percentage of anaemia attributable to hookworm. -
r37980778c78--a4d7090cf2db2b5bc489aff26e300bc8
Emergence rate of adult Glossina brevipalpis irradiated as pupae with different doses and on different days Post Larviposition (PL). -
Evaluation of an alpha-cypermethrin + PBO mixture long-lasting insecticidal n...
Abstract Background Long-lasting insecticidal nets (LLINs) are the primary method of malaria prevention. However, the widespread resistance to pyrethroids among major malaria... -
Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin sn...
Abstract Background The African Programme for Onchocerciasis Control has proposed provisional thresholds for the prevalence of microfilariae in humans and of L3 larvae in... -
Risk factors for <i>P</i>. <i>vivax</i> recurrence between days 7 and 42 in p...
Risk factors for P. vivax recurrence between days 7 and 42 in patients treated with dihydroartemisinin-piperaquine alone. -
Univariate and multivariate linear regression analyses of factors associated ...
Univariate and multivariate linear regression analyses of factors associated with the GRA score at 3 months (n = 80). -
Antiplasmodial profile of selected compounds from Malaria Box: in vitro evalu...
Abstract Background Artemisinin-based combination therapy (ACT) is used as the first-line treatment of uncomplicated malaria caused by the Plasmodium falciparum parasite and... -
r37980778c78--f1db7024cd544b40c98ce68432b93412
Correlations between the GRA and the changes from baseline of all variables at 3 & 6 months. -
Listing of most frequently-reported AEs (>15% overall) and all AEs of special...
AE, adverse event; GI, gastrointestinal. -
r37980778c78--eec96bfc921ddb61a181a495c99af5c1
List of serious adverse events (SAE) occurring in snakebite victims with neurotoxic signs randomized to either a low or a high initial dose of antivenom. -
r37980778c78--674c9aff40dc39258f6632c20fbc422a
Details of approved drugs predicted to target P. falciparum proteins that have not been tested. -
r37980778c78--bc6768b2a91f7e331377d1fbd676dddf
Frequency table of tuberculosis culture (TB-CX) Test Turnaround Time (TAT). -
Comparison of biochemical characteristics of experimental animals.
Comparison of biochemical characteristics of experimental animals.
